Claritev Corporation

CTEV Healthcare Health Information Services

Claritev Corporation’s revenue for fiscal 2025 (year ended December 2025) was $965.4 million, up 3.74% from fiscal 2024. In the quarter to June 2026, revenue grew 6.59%, EPS grew 8.40%, free cash flow grew 49.1% and total debt was flat, each against the same quarter a year earlier. Insiders bought in the last twelve months.

22.12 1.74 −7.29%
Market cap
$404.4M
P/E
0.0×
Fwd P/E
−1.6×
Dividend yield
—
F-score
5/9
Altman Z
−0.40
Beneish M
−2.59
Dividend safety
n/a

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Revenue
1,040.88 982.90 937.76 1,117.60 1,079.72 961.52 930.62 965.41
Revenue Growth
5.90% (5.57%) (4.59%) 19.18% (3.39%) (10.95%) (3.21%) 3.74%
Gross Profit
891.42 833.29 619.09 942.31 875.62 726.06 691.22 712.00
Operating Income
427.54 368.21 (131.82) 386.12 (362.73) 161.98 (1,389.93) 28.77
EBT
44.33 10.51 (546.91) 135.45 (560.74) (107.06) (1,770.71) (373.08)
Income after Tax
36.22 9.71 (520.56) 102.08 (572.91) (91.70) (1,645.83) (284.28)
Net Income Common
36.22 9.71 (520.56) 102.08 (572.91) (91.70) (1,645.83) (284.28)
EPS (Diluted)
3.49 0.93 (44.80) 6.40 (36.00) (5.60) (101.92) (17.30)
Shares (Diluted, Weighted)
10.39 10.39 11.77 16.29 15.97 16.13 16.15 16.43
Gross Margin
85.64% 84.78% 66.02% 84.32% 81.10% 75.51% 74.27% 73.75%
EBIT Margin
41.07% 37.46% (14.06%) 34.55% (33.60%) 16.85% (149.35%) 2.98%
Net Profit Margin
3.48% 0.99% (55.51%) 9.13% (53.06%) (9.54%) (176.85%) (29.45%)
Free Cash Flow Margin
21.98% 22.17% 32.69% 28.64% 26.18% 6.54% (1.13%) (1.27%)
EBITDA
813.86 767.66 271.86 810.44 63.47 598.43 (942.52) 482.70
EBIT
427.54 368.21 (131.82) 386.12 (362.73) 161.98 (1,389.93) 28.77

Show all line items

In millions of $ except per-share values · columns are period end dates